Matthew Fox, an employee at the Realeaf Cannabis trailer north of Saskatoon, warns customers interested in trying Marvin’s Premium Candy Co. Cherry edibles with a simple “Good luck.” The trailer, owned by the Saulteaux First Nation, operates under its own regulations, diverging from the federal Cannabis Act’s restrictions on THC content in cannabis gummies.
Realeaf’s website emphasizes the First Nations’ right to self-governance, allowing them to set their own rules regarding cannabis products. The trailer showcases various colorful edibles like Buddha Boys and Mellow Vibes, including the infamous Marvin’s cherry-flavored edibles. These candies, known as the ‘talking to God’ section, contain a staggering 8,000 mg of THC in a pack of four, making each gummy 200 times more potent than the federal standard.
Fox, with over two years of experience at the trailer, disclosed his personal encounter with high-potency products, having consumed 1,500 milligrams of THC once, resulting in a three-day high. Health experts like University of Saskatchewan neuroscientist John Howland stress the importance of raising awareness about the risks associated with cannabis consumption, especially with the surge in hospital visits due to cannabis-related psychosis in Saskatchewan.
In a recent murder trial in Saskatoon, forensic psychiatrist Shabehram Lohrasbe highlighted the evolving landscape of cannabis products, noting a significant increase in potency compared to earlier generations. The trial delved into the impact of cannabis use on the accused’s mental state and its potential role in severe psychotic episodes.
Researchers at the University of Saskatchewan, Robert Laprairie and John Howland, emphasize the need for continued public research on the effects of high-potency cannabis, particularly on youth consumers. They underscore the importance of monitoring THC levels, consumption frequency, and family history to better understand the risks associated with cannabis use and advocate for ongoing collaboration with health authorities to address emerging challenges in cannabis regulation.